期刊文献+

阿托伐他汀钙对实验性脑缺血MMP-9表达变化的影响

Effects of atorvastatin on the expression of MMP-9 after cerebral ischemia/reperfusion injury in rats
下载PDF
导出
摘要 目的探讨阿托伐他汀钙对大鼠脑缺血再灌注后脑组织中MMP-9mRNA及蛋白表达的影响。方法采用大脑中动脉线栓法制备脑缺血再灌注模型,参考Longa5分制法在动物麻醉清醒后进行评分,应用原位杂交和免疫组化法检测MMP-9mRNA及蛋白表达。结果大鼠脑缺血再灌注后缺血脑组织中MMP-9mRNA和蛋白表达增加(P<0.01),24h达高峰;阿托伐他汀钙干预治疗后能减少缺血脑组织中MMP-9mRNA和蛋白表达(P<0.05);降低神经功能缺损评分(P<0.05)。结论阿托伐他汀钙能抑制大鼠脑缺血再灌注后脑组织中MMP-9mRNA及蛋白表达,减轻缺血再灌损伤。 Objective To investigate the impact of the atorvastatin on the expression of MMP-9 in the brain tissue after ischemia/reperfusion(I/R) injury. Methods Rats were subjected to cerebral I/R injury through the occlusion of the middle cerebral artery. Neurological deficits were determined by Longa's score. The expression of MMP-9 was detected by immuno-histochemical analysis, and the expression of MMP-9 mRNA was detected by the in situ hybridization method. Restilts The expression of MMP-9 mRNA and protein in the ischemic territory increased after cerebral ischemia( P 〈 0. 01 ), peaking at 24h after ischemia. Atorvastatin could decrease the expression of MMP-9 mRNA and protein( P 〈 0. 05 ) and im- prove the Longa's score ( P 〈0. 05) . Conclusions Atorvastatin-calcium protect the( brain tissue against ischemia reperfusion injury through inhibiting the expression of MMP-9 after focal cerebral ischemia reperfusion in rats.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2007年第5期276-279,共4页 Chinese Journal of Nervous and Mental Diseases
基金 湖南省卫生厅课题(编号:B2005023) 湖南省自然科学基金(编号:02JJY3028) 教外司留学回国基金(编号:教外司留[2006]331号)
关键词 阿托伐他汀钙 脑缺血再灌注 炎症反应 基质金属白酶9 Atorvastatin-calcium Ischemia/reperfusion Inflammatory MMP-9
  • 相关文献

参考文献8

  • 1Zhang FY, Chen XC, Ren HM,et al. Effects of ischemic preconditioning on blood-brain barrier permeability and MMP-9 expression of ischemic brain. Neurological research,2006,28 ( 1 ): 21.
  • 2Liu R, Wen Y, Perez E,et al. 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res,2005,1060( 1 -2) :55.
  • 3Ercan E, Tengiz I, Altuglu I, et al. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. Polish Heart Journal,2004,60 ( 5 ) :458.
  • 4Xu Z, Zhao S, Zhou H, et al. Atorvastatin lowers plasma matrix metalloproteinase- 9 in patients with acute coronary syndrome. Clinical Chemistry, 2004,50 ( 4 ) :750.
  • 5Chandrasekar B, Mummidi S, Mahimainathan L, et al. Interleukin-18induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB-and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem, 2006,281 (22) :15099.
  • 6Gu W, Zhao H, Yenari MA,et al. Catalase over-expression protects striatal neurons from transient focal cerebral ischemia. Neuroreport,2004,15(3) :413.
  • 7Ding Y,Li J, Rafols JA,et al. Reduced brain edema and matrix metalloproteinase (MMP) expression by pre-reperfusion infusion into ischemic territory in rat. Neuroscience Letters ,2004,372 (1 -2) :35.
  • 8Asahi M, Asahi K, Jung JC, et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab ,2000,20 ( 12 ): 1681.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部